Index
By TNW
About Index
Trending news
Analyze
Pricing
Sign up or sign in
Achillion Pharmaceuticals
Work at Achillion Pharmaceuticals?
Add yourself to this profile
532
Achillion Pharmaceuticals
An innovative pharmaceutical company dedicated to meeting the needs of patients with HCV & ultra-rare diseases. Disclaimer on our site
Edit Profile
achillion.com
Health Care
Technology
>
Biotechnology
B2c
Founded in
1998
Raised
$50.1M
More info
Elsewhere
Companies in the same industry
NestSense
Lysosomal Therapeutics
BioVentrix
Pfizer Inc.
Ironwood Pharma
Blueprint Medicines
Acorda Therapeutics
Immune Design
Endocyte
Epinex Diagnostics
Alexa global traffic share
Twitter followers
Overview
Funding
1
Add info
Latest funding
Venture capital
$50,100,000
Pappas Ventures
,
Clarus Ventures
,
Domain Associates
, +1
Employees
Unknown size
Locations
Unknown
Help us complete this profile
The Motley Fool
Why Achillion Pharmaceuticals Is Down Big in 2016
The Motley Fool
Why Achillion Pharmaceuticals Jumped 10% in May
The Motley Fool
Why Achillion Pharmaceuticals Shares Crashed 37% in January
Stock markets
Health
The Motley Fool
Why Achillion Pharmaceuticals Shot 30% Higher in November --
Health
Earnings
Stock markets
The Motley Fool
Why Achillion Pharmaceuticals Shares Soared in October --
Stock markets
Health
The Motley Fool
Why Achillion Pharmaceuticals Shares Are Roaring Higher Today --
Stock markets
Health
NestSense
BioVentrix
Pfizer Inc.
Ironwood Pharma
Blueprint Medicines
Acorda Therapeutics
Immune Design
Endocyte
Epinex Diagnostics